SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Novel NDUFA12 variants are associated with isolated complex I defect and variable clinical manifestation.

Torraco, A; Nasca, A; Verrigni, D; Pennisi, A; Zaki, MS; Olivieri, G; Assouline, Z; Martinelli, D; Maroofian, R; Rizza, T; et al. Torraco, A; Nasca, A; Verrigni, D; Pennisi, A; Zaki, MS; Olivieri, G; Assouline, Z; Martinelli, D; Maroofian, R; Rizza, T; Di Nottia, M; Invernizzi, F; Lamantea, E; Longo, D; Houlden, H; Prokisch, H; Rötig, A; Dionisi-Vici, C; Bertini, E; Ghezzi, D; Carrozzo, R; Diodato, D (2021) Novel NDUFA12 variants are associated with isolated complex I defect and variable clinical manifestation. Hum Mutat, 42 (6). pp. 699-710. ISSN 1098-1004 https://doi.org/10.1002/humu.24195
SGUL Authors: Maroofian, Reza

[img]
Preview
PDF Accepted Version
Available under License ["licenses_description_publisher" not defined].

Download (658kB) | Preview

Abstract

Isolated biochemical deficiency of mitochondrial complex I is the most frequent signature amongst mitochondrial diseases and is associated with a wide variety of clinical symptoms. Leigh syndrome represents the most frequent neuroradiological finding in patients with complex I defect and >80 monogenic causes have been involved in the disease. In this report, we describe 7 patients from four unrelated families harbouring novel NDUFA12 variants, 6 of them presenting with Leigh syndrome. Molecular genetic characterization was performed using next generation sequencing combined with the Sanger method. Biochemical and protein studies were achieved by enzymatic activities, blue native gel electrophoresis and Western blotting. All patients displayed novel homozygous mutations in the NDUFA12 gene leading to the virtual absence of the corresponding protein. Surprisingly, despite in none of the analyzed patients NDUFA12 protein was detected, they present a different onset and clinical course of the disease. Our report expands the array of genetic alterations in NDUFA12 and underlines phenotype variability associated with NDUFA12 defect. This article is protected by copyright. All rights reserved.

Item Type: Article
Additional Information: This is the peer reviewed version of the following article: Torraco, A., Nasca, A., Verrigni, D., Pennisi, A., Zaki, M. S., Olivieri, G., Assouline, Z., Martinelli, D., Maroofian, R., Rizza, T., Di Nottia, M., Invernizzi, F., Lamantea, E., Longo, D., Houlden, H., Prokisch, H., Rötig, A., Dionisi-Vici, C., Bertini, E., … Diodato, D. (2021). Novel NDUFA12 variants are associated with isolated complex I defect and variable clinical manifestation. Human Mutation, 42, 699– 710, which has been published in final form at https://doi.org/10.1002/humu.24195. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.
Keywords: Leigh syndrome, NADH ubiquinone oxidoreductase, NDUFA12, mitochondrial disease, 0604 Genetics, 1103 Clinical Sciences, Genetics & Heredity
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Hum Mutat
ISSN: 1098-1004
Language: eng
Dates:
DateEvent
19 May 2021Published
25 March 2021Published Online
6 March 2021Accepted
Publisher License: Publisher's own licence
PubMed ID: 33715266
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/113090
Publisher's version: https://doi.org/10.1002/humu.24195

Actions (login required)

Edit Item Edit Item